Long-Term Outcome of the First Completely Leadless Cardiac Resynchronization Therapy in the United States

Donald Mehlhorn; Sankalp Patel; Dhiran Verghese; Hashem Azad; Dinesh Sharma

doi:10.1016/j.jaccas.2023.102020

Long-Term Outcome of the First Completely Leadless Cardiac Resynchronization Therapy in the United States

JACC Case Rep. 2023 Sep 16:24:102020. doi: 10.1016/j.jaccas.2023.102020. eCollection 2023 Oct 18.

Authors

Donald Mehlhorn¹, Sankalp Patel², Dhiran Verghese², Hashem Azad³, Dinesh Sharma²

Affiliations

¹ Naples Community Hospital, GME, Naples, Florida, USA.
² Naples Heart Institute (Rooney Heart), Naples, Florida, USA.
³ SWICFT Cardiology, Naples, Florida, USA.

Abstract

Completely leadless cardiac resynchronization therapy is feasible with the combination of Micra AV pacemaker (Medtronic Inc) and WiSE-CRT (EBR Inc) systems. Several reports have highlighted this combination in Europe. This case report presents a 1- year follow-up the first reported concomitant use of the leadless systems in the United States. (Level of Difficulty: Advanced.).

Keywords: WiSE CRT system; biventricular pacing; cardiac resynchronization therapy; endocardial left ventricular pacing; leadless pacemaker.

Publication types

Case Reports